课题基金 / 基金详情

Initiation of opioid agonist therapy with daily witnessed methadone or flexible take-home dosing of buprenorphine/naloxone for prescription opioid users: A pragmatic patient-centred randomized controlled trial-QC/Maritimes

Initiation of opioid agonist therapy with daily witnessed methadone or flexible take-home dosing of buprenorphine/naloxone for prescription opioid users: A pragmatic patient-centred randomized controlled trial-QC/Maritimes
处方阿片类药物使用者每日目击美沙酮或灵活服用丁丙诺啡/纳洛酮开始阿片类激动剂治疗：一项以患者为中心的实用随机对照试验 - QC/Maritimes
批准号：
339660
负责人：
Bruneau Julie
金额：
$80.86万
依托单位：
Universit de Montral
依托单位国家：
加拿大
项目类别：
Directed Grant
财政年份：
2015
资助国家：
加拿大
项目状态：
已结题
起止时间：
2015-10-01 至 2019-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=339660&lang=en
关键词：
.

项目摘要

项目成果

Bruneau Julie的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The CRISM Quebec Node: building evidence for preventing, treating and reducing drug related harms
Chronic non-cancer pain, substance use, and related harms: Towards an optimal treatment pathway for people who inject drugs in the context of the opioid crisis
CRISM Urgent Guideline Activities Related to COVID-19
Chronic non-cancer pain, substance use, and related harms: Towards an optimal treatment pathway for people who inject drugs in the context of the opioid crisis